Orexigen (OREX) Higher Again, Shares Now Up ~90% in June Following Arena (ARNA), Analyst Upgrade
Tweet Send to a FriendGet Alerts OREX Hot Sheet
Up)
Trade OREX Now!
Investors just can't get enough Orexigen Therapeutics (Nasdaq: OREX) following the FDA decision on Arena Pharmaceutircals (Nasdaq: ARNA) lorcaserin Wednesday and JPMorgan upgrade Thursday. Shares are up an additional 7.6 percent Friday, pushing shares up about 90 percent for the month of June.
Stock volatility is up about 2 percent from Thursday's close.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Stock volatility is up about 2 percent from Thursday's close.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Can AMD (AMD) Shake Off the Goldman Downgrade?
- Amid Tesla (TSLA) Squeeze, Option Prices Hit Record Highs
- Real Goods Solar (RSOL) Goes Parabolic
Create E-mail Alert Related Categories
Insiders' Blog, Momentum MoversRelated Entities
JPMorgan
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
